Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Idrugs : the Investigational Drugs Journal|January 15, 2005
Recent advances in the research and development of CB1 antagonistsRoger A Smith, Zahra FathiCurrent Opinion in Drug Discovery & Development|October 27, 2004
Recent developments in the discovery of protein kinase inhibitors from the urea classJacques Dumas, Roger A Smith, Timothy B LowingerCurrent Topics in Medicinal Chemistry|July 18, 2006
Recent advances in the research and development of RAF kinase inhibitorsRoger A Smith, Jacques Dumas, Lila Adnane, et al.Current Pharmaceutical Design|October 9, 2002
Design and discovery of small molecules targeting raf-1 kinaseTimothy B Lowinger, Bernd Riedl, Jacques Dumas, et al.Annals of Surgical Oncology|April 25, 2012
A stepwise approach to transanal endoscopic microsurgery for rectal cancer using a single-incision laparoscopic portRoger A Smith, Daniel A Anaya, Daniel Albo, et al.Optics Express|May 4, 2016
Double-heralded generation of two-photon-states by spontaneous four-wave-mixing in the presence of noiseRoger A Smith, Dileep V Reddy, Dashiell L P Vitullo, et al.Nature Reviews. Drug Discovery|October 4, 2006
Discovery and development of sorafenib: a multikinase inhibitor for treating cancerScott Wilhelm, Christopher Carter, Mark Lynch, et al.Physical Review Letters|March 11, 2017
Observation of Interaction of Spin and Intrinsic Orbital Angular Momentum of LightDashiell L P Vitullo, Cody C Leary, Patrick Gregg, et al.Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Solid-phase synthesis and investigation of benzofurans as selective estrogen receptor modulatorsRoger A Smith, Jinshan Chen, Mary M Mader, et al.Molecular Cancer Therapeutics|May 28, 2021
ASN004, A 5T4-targeting scFv-Fc Antibody-Drug Conjugate with High Drug-to-Antibody Ratio, Induces Complete and Durable Tumor Regressions in Preclinical ModelsRoger A Smith, David J Zammit, Nitin K Damle, et al.Pageof 2